281 related articles for article (PubMed ID: 18635422)
21. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients.
Malyszko J; Malyszko JS; Brzosko S; Wolczynski S; Mysliwiec M
J Clin Endocrinol Metab; 2004 Sep; 89(9):4620-7. PubMed ID: 15356072
[TBL] [Abstract][Full Text] [Related]
22. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.
Takebayashi K; Suetsugu M; Wakabayashi S; Aso Y; Inukai T
Metabolism; 2007 Apr; 56(4):451-8. PubMed ID: 17378999
[TBL] [Abstract][Full Text] [Related]
23. Inflammation and endothelial activation are linked to renal function in long-term kidney transplantation.
Cottone S; Palermo A; Vaccaro F; Mulè G; Guarneri M; Arsena R; Vadalà A; Cerasola G
Transpl Int; 2007 Jan; 20(1):82-7. PubMed ID: 17181657
[TBL] [Abstract][Full Text] [Related]
24. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
[TBL] [Abstract][Full Text] [Related]
25. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
[TBL] [Abstract][Full Text] [Related]
26. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
27. Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance.
Cekmez F; Canpolat FE; Pirgon O; Çetinkaya M; Aydinoz S; Suleymanoglu S; Ipcioglu OM; Sarici SU
Cytokine; 2011 Nov; 56(2):387-91. PubMed ID: 21742512
[TBL] [Abstract][Full Text] [Related]
28. Unfractionated heparin but not enoxaparin causes delayed plasma PAI-1 depletion in hemodialysis patients: a prospective study.
Naumnik B; Pawlak K; Mys'liwiec M
Clin Appl Thromb Hemost; 2009 Feb; 15(1):84-91. PubMed ID: 17895513
[TBL] [Abstract][Full Text] [Related]
29. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.
Vaccaro F; Mulè G; Cottone S; Soresi M; Giannitrapani L; Vadalà A; Sparacino V; Calabrese S; Picone FP; Montalto G; Cerasola G
Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459
[TBL] [Abstract][Full Text] [Related]
30. Adipokines: a novel link between adiposity and carotid plaque vulnerability.
Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Kostakis A; Liapis CD
Eur J Clin Invest; 2012 Dec; 42(12):1278-86. PubMed ID: 23033969
[TBL] [Abstract][Full Text] [Related]
31. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
[TBL] [Abstract][Full Text] [Related]
32. Activation of endothelial and coagulation systems in left ventricular assist device recipients.
John R; Panch S; Hrabe J; Wei P; Solovey A; Joyce L; Hebbel R
Ann Thorac Surg; 2009 Oct; 88(4):1171-9. PubMed ID: 19766802
[TBL] [Abstract][Full Text] [Related]
33. Dyslipidemias and fibrinolysis.
Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Auteri A
Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
[TBL] [Abstract][Full Text] [Related]
34. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
Blann AD; Dobrotova M; Kubisz P; McCollum CN
Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
[TBL] [Abstract][Full Text] [Related]
35. Apelin and visfatin: unique "beneficial" adipokines upregulated in obesity?
Bełtowski J
Med Sci Monit; 2006 Jun; 12(6):RA112-9. PubMed ID: 16733497
[TBL] [Abstract][Full Text] [Related]
36. Adipokines, linking adipocytes and vascular function in hemodialyzed patients, may also be possibly related to CD146, a novel adhesion molecule.
Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
Clin Appl Thromb Hemost; 2008 Jul; 14(3):338-45. PubMed ID: 18160586
[TBL] [Abstract][Full Text] [Related]
37. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
[TBL] [Abstract][Full Text] [Related]
38. Relationship between serum adipocyte fatty acid-binding protein and endothelial/hemostatic markers in dyslipidemic subjects.
Karasek D; Vaverkova H; Frysak Z; Orsag J; Novotny D; Halenka M; Slavik L
Neuro Endocrinol Lett; 2012; 33 Suppl 2():26-31. PubMed ID: 23183506
[TBL] [Abstract][Full Text] [Related]
39. Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure.
Cottone S; Mulè G; Amato F; Riccobene R; Vadalà A; Lorito MC; Raspanti F; Cerasola G
J Nephrol; 2002; 15(6):643-8. PubMed ID: 12495277
[TBL] [Abstract][Full Text] [Related]
40. Patients with antiphospholipid syndrome display endothelial perturbation.
Cugno M; Borghi MO; Lonati LM; Ghiadoni L; Gerosa M; Grossi C; De Angelis V; Magnaghi G; Tincani A; Mari D; Riboldi P; Meroni PL
J Autoimmun; 2010 Mar; 34(2):105-10. PubMed ID: 19656656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
